Vancouver, B.C. – March 11, 2020 – WELL Health Technologies Corp. (TSX: WELL) (“WELL” or the “Company”), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, today announced that Hamed Shahbazi, Chairman and CEO, will be participating in the Virtual 33rd Annual Roth Conference. To be held March 15th – 17th, the Virtual 33rd Annual Roth Conference provides institutional investors, private equity and venture capital investors with access to growth companies from a broad range of industries.
Mr. Shahbazi is a guest speaker on a panel titled “Uncovering Growth Opportunities Listed North of the Border”, taking place at 10am EST (7am PST) on Wednesday March 17, 2021. The panel discussion will be moderated by Brady Fletcher, President of Roth Canada, and will cover such topics as how WELL has leveraged its public listing to finance the Company’s ambitious M&A growth strategy and the role of the CEO as a capital allocator.
To view the panel discussion, use the following webcast link:
https://wsw.com/webcast/roth35/panel20/2105370
To register for the conference and schedule a one-on-one meeting with WELL management, contact your representative at Roth Capital Partners, LLC.
About WELL Health Technologies Corp.
WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. As such, WELL owns and operates 27 primary healthcare clinics, is Canada's third largest digital Electronic Medical Records (EMR) supplier serving over 2,200 medical clinics, operates a leading national telehealth service in Canada and the United States, and is a provider of digital health, billing and cybersecurity related technology solutions. WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL“. To access the Company’s telehealth service, visit: tiahealth.com and for corporate information, visit: www.WELL.company.
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Pardeep S. Sangha
Vice President Corporate Strategy and Investor Relations
604-572-6392
